This meta-analysis of 67 observational studies analyzes the effectiveness and adverse event rate of omalizumab therapy in patients with chronic idiopathic urticaria and compares these findings with those of randomized clinical trials conducted among similar patients.
https://ift.tt/2PugP8I
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου